Elizabeth G Nabel Moderna, Inc. (MRNA) insider trading activity

Elizabeth G Nabel is Director of Moderna, Inc.. Currently has a direct ownership of 3,084 shares of MRNA, which is worth approximately $100,939. The most recent transaction as insider was on Apr 30, 2025, when has been sold 979 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.08K

46.51% 3M change

46.51% 12M change

Total Value Held $100,939

ELIZABETH G NABEL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 30 2025	BUY Exercise of conversion of derivative security	-	979 Added 24.1%	3,084 Common Stock
May 03 2024	BUY Exercise of conversion of derivative security	-	732 Added 25.8%	2,105 Common Stock
Apr 28 2023	BUY Exercise of conversion of derivative security	-	670 Added 32.79%	1,373 Common Stock
Apr 28 2022	BUY Exercise of conversion of derivative security	-	703 Added 50.0%	703 Common Stock
Jul 15 2020	SELL Open market or private sale	$6,497,964 $87.84 p/Share	73,975 Reduced 100.0%	0 Common Stock
Jul 15 2020	BUY Exercise of conversion of derivative security	$1,044,139 $17.51 p/Share	59,631 Added 44.63%	73,975 Common Stock
May 12 2020	SELL Open market or private sale	$1,980,000 $66.0 p/Share	30,000 Reduced 67.65%	14,344 Common Stock
Dec 11 2018	BUY Conversion of derivative security	-	13,679 Added 23.58%	44,344 Common Stock

Also insider at

MDT

Medtronic plc Healthcare

Director

ACCD

Accolade, Inc. Healthcare

LYEL

Lyell Immunopharma, Inc. Healthcare

EGN